Introduction
Metal-based compounds have been largely used and studied as chemotherapeutic drugs since the discovery of the cytotoxic properties of cisplatin (cis-[Pt(NH 3 ) 2 Cl 2 ]) in the late 1960s; [1] [2] [3] after its approval by the US Food andD rug Administration in 1978, cisplatin has become am ilestone in antineoplastic treatment. [3, 4] The therapeutic relevance of platinum-based compounds has led researchers to elucidate their mechanisms of action, with the aim to improve their efficacy on neoplasms and to hamper adverse reactions in healthyt issues.
It is known that the metal centerinm etal-based drugs is the pivotalm oiety that acts as the anticancer "weapon", whereas the organic part of the molecule (ligand) playso ther key roles, such as stabilizing the metal oxidation state, reducing systemic toxicity, and tuning water solubility.U nder physiological-like conditions, metal centers, being positivelycharged, are favored to bind to negatively charged biomolecules, such as enzymes and nucleotides,o ru ndergo redox processes. [5] [6] [7] [8] On the other hand, the mechanism of biological action of metal compounds is, in severalc ases, not fully elucidated. As an example, in anticancer metallodrugs,D NA is not alwayst he primary target as it appearsf or cisplatin. [6] [7] [8] [9] In addition, the typeo fl igands (O-, N-, S-donors, monodentate or chelating ones, etc.), the nature, and the oxidation state of the metal center determine the hallmarks of the final compound such as its coordination geometry and stereochemistry and, ultimately,i ts biological behavior. [10] [11] [12] [13] [14] These observations, together with the poor toxicological profile of cisplatin, whose clinical use causes adversee ffects and the occurrence of resistance, [15, 16] have prompted the research into alternative platinum-based compounds, in order to find drugs with ab etter chemotherapeutic index in terms of toxicity-activity ratio. [15, 17, 18] In the last years, we have broken into this research scene with our nonplatinum-based coordination compounds. These molecules are metal-dithiocarbamato( dtc) complexes potentially able to combine the cytotoxic activity of the related metal center( e.g. Au I,III ,R u II,III ,Z n II ,C u II )w ith lack of toxicity owing to the inherentc hemoprotective action of the dtc ligand. [19, 20] Overall, our findings provide evidence for the importance of stabilizingt he heavy metal centeri no rder to prevent its nonspecific reactivity that would give rise to systemic toxicity. [21] Up to now,t he most promising resultsh ave been obtained with gold(III) derivativeso ft he type [Au III X 2 (dtc)] (X = Cl, Br;d tc = various dithiocarbamato ligands). These compounds closely reproduce the structural features of cisplatin, and most of them are endowed with good anticancer activity, together with av ery low or negligible systemic toxicity. [22] [23] [24] [25] [26] In parallelt ot he synthesis of gold chemotherapeutics, we have also been synthetizing and studying coordination compounds of ruthenium and copper with pyrrolidinedithiocarbaTransition metals offer many possibilities in developing potent chemotherapeutic agents. They are endowed with av ariety of oxidation states,a llowing for the selection of their coordination numbersa nd geometries via the choice of properl igands, leadingt ot he tuning of their final biological properties. We report here on the synthesis, physico-chemical characteriza- mate (PDT) as al igand. In this context, we found that the presence of PDT strongly affects the final biological activity. In fact, we recorded an encouraging cytotoxic activity in the nano and micromolar range against human non-small-cell lung cancer, two estrogen-receptor-a-positive breast cancer cell lines, the triple negative MDA-MB-231 breast cancerc ell line, androgenreceptor-independentp rostate tumor,o varian and cervical squamousc arcinoma cell lines, andt he corresponding cisplatin-resistant subclones. [27, 28] Therefore, in the present work we have combined the chelating ligand PDT with gold metal in a1 :1 metal-to-ligand stoichiometry with the remaining coordination sites occupied by two cis-halogen ions which may undergo hydrolysis in the physiological milieu.
In particular, we report on the synthesis of two new gold(III) pyrrolidinedithiocarbamates with the general formula [Au III X 2 (PDT)] as shown in Figure 1 , wherein Xi se ither Br (complex 1)o rC l( complex 2). Their physico-chemical characterization was followed by the evaluation of their in vitro cytotoxicity on HeLa (cervical cancer), HCT116 (colon neoplasia), SAOS (osteosarcoma), and MEF-NF1 À/À (immortalized primary embryonic fibroblast) cancer cell lines. The solution behavior of both complexes was also studied under physiological-like conditions by UV/Vis spectrophotometry.T hen, the cell-death-inducing mechanisms were explored by investigating whether the compounds affect redox equilibrium or influence the mitochondrial permeability transition pore (PTP) activity.
Results and Discussion

Synthesis and characterization of the gold(III) complexes
Twog old(III)-pyrrolidinedithiocarbamato derivativesw erep repared in very good yields via direct reactiono ft he salt ligand ammonium PDT with the metal precursor potassium tetrabromoaurate(III) or potassium tetrachloroaurate(III) under equimolar conditions at room temperature. The purity of all final compounds was higher than 95 %( by thermogravimetric ande lemental analysis). Both the startinga mmonium PDT and the corresponding gold(III)-dithiocarbamatod erivatives 1 and 2 ( Figure 1 ) have been characterized by means of several techniques in order to confirm the expected stoichiometry as well as to investigate their structuralfeatures.
Elemental and thermogravimetric analyses highlighted av ery good correlation between calculated andf ound values. In particular,t hermald egradation primarily takes place via two steps, leadingt ot he formation of metallicg old, in agreement with literature data [29, 30] (Table 1) . The presence of an endothermic differential scanningc alorimetry (DSC) peak at about 1064 8C( gold T melt )a long with no weightl oss further confirms the decomposition to elemental gold.T he first step is likely due to the formation of gold(I)t hiocianate upon reductive elimination as reported in literature for similarg old(III) dithiocarbamato compounds. [31, 32] The elucidation of the coordination mode and the strength of the bonds between the metal andt he ligand donor atoms is of paramount importance in the characterization of metal derivatives designed for medicinal applications. In this regard, mediuma nd far FT-IR spectroscopy are among the best diagnostic tools. Ta ble 2h ighlights that the band associated with the NÀCSS stretching shifts toward higher energies when passing from the free ligand to the corresponding gold derivatives due to an increased carbon-nitrogen double bond character following the coordination. [33] [34] [35] The detection of as ingle band at about 1000 cm
À1
,a ttributable to the n a (SÀCÀS) for both gold(III) complexes,p oints out that the ÀNCSS moiety chelates the metal center in as ymmetrical bidentate mode in agreement with our data on other complexes. [21, 24, 36] Ab and, detectable in the range 420-630cm À 1 and commonly ascribed to the n s (SÀCÀS) vibration, is observed for both the complexes and the free dithiocarbamato ligand (Table 2) . [29, [37] [38] [39] [40] It is interesting to underline that this absorption is associateda lso with some Mh s s iC ring deformations, as previously shown by detailed FT-IR isotopics tudies on variousd ithiocarbamato complexes. [41] The presence of two new bands in the range 370-420 cm
,a bsent in the IR spectrum of the free ligand and ascribable to gold(III)-sulfur vibrations (n s and n a ), further accountsfor ac helated coordination geometry. [38] Notably,onthe basis of the energies recorded fort he n a/s (SÀAuÀS), compound 2 is characterized by as lightly stronger metal-ligand bond, which indirectly determines ah igher stretching frequency for the NÀCSS bond (Table 2) . [42] Twoh alides complete the coordination sphere in [a] Endo = endothermic, exo = exothermic. www.chemistryopen.org a cis-geometry as shown by the appearance of two new bands (n a/s (XÀAuÀX)) at 240/218a nd 362/315cm À 1 for the complex 1 and 2,r espectively. [43, 44] The other main frequencies,a scribable to the organic alkylic backbone, seem to be negligibly affected by metal coordination, except for the disappearance of the broad band at 3102 cm À1 (n a/s (NH 4 + )) (Table2). Concerning the NMR characterization, one and two-dimensional spectra ( 1 H, 13 CHMBC,T able 3) showed an upfield shift (about 20 ppm with respectt ot he free ligand) for the signal of the dithiocarbamato carbon atom for both complexes (at about 190 ppm), along with the disappearance of the NH 4 + proton peak (at 7.33 ppm), confirming the formation of the gold(III) derivatives. In comparison with the spectrum recorded for ammonium PDT,a ll 13 Cr esonances are shifted at higher fields. Conversely,u pon metal coordination the 1 Hm ultiplets of all the methylene groups are shifteda tl ower fields, thus pointingo ut opposite shield effects on the two investigated NMR-activen uclei. By meanso fN MR kinetics, we checked the stabilityo ver time of both complexes in D 6 -dimethylsulfoxide (DMSO)a sp redissolution of our hydrophobic compounds in this organic solvent is necessary to carry out the biological tests in cell culture medium.
UV/Vis spectrophotometric studies
When studying metallodrugs, it is necessary to test their stability under physiological conditions. [5] Therefore, detailed spectrophotometric studies were carried out for both complexes dissolved in DMSO (reference solvent) ands aline solution.I n order to better investigate the possible reactivity in both media, several electronic spectra were recorded up to 24 hours. It is worth pointing out that our compounds show ag ood antiproliferative activity already after af ew hours of treatment. [22] Accordingly,i nt his work we highlight only the chemicala nd biological behavior after at hree-hour treatment. The kinetic behavior of the coordination compounds 1 and 2 was first monitored in DMSO (Figure2)a t3 78 Ca nd ac oncentration of 100 mm (main features collected in Table 4 ).
Band 1and band 2have been ascribed in literature to intraligand p* ! p transitions mainly located in the ÀNCSa nd ÀCSS moieties, respectively. [29, 38] Moreover,a ni ntraligand p* ! n transition, where n is the in-plane nonbonding sulfur orbital, should be recorded at around 340 nm [45] but is not observable owing to the overlap with the more intense adjacent bands. A weak band at about 380 nm is visible only for the coordination compound 1 (labeled as band 3i nF igure2)a nd is attributable to an intramolecular L ! Mc harget ransfer involving the M nd orbitals and the dithiocarbamato p* system. [46, 47] However, owing to the quite high oxidizing powero fA u III ,t his transition has been ascribed also to an electron transfer of the type u ! g from a4 porbital of the bromide ligands to the lowest unfilled 5d orbitalo ft he metal center. [48] Its low intensity can be explained by ap oor overlap between the 5d metal orbitala nd the involved 4p orbital (p symmetry). [48] For both complexes,n om ajor alteration of the bands related to the metal-ligandc hromophore waso bserved over time. This behaviori sl ikely due to the large stabilization effects broughta bout by the dithiocarbamato ligand.S uch stability was furtherc onfirmed in the same solvent by 1 HNMR over three hours. On the basis of these results, DMSO was used to dissolve 1 and 2 prior to performing all the biological tests (< 0.5 % v/v)a nd was taken as reference mediumi nt he discussion of the spectral features detected in saline solution. In this aqueous environment, the evolution with time was likewise followed by UV/Vis spectrophotometry for three hours at 37 8C (Figure 3) , with both compounds being previouslyd issolved in DMSO (final concentration 100 mm,a t0 .8 %a nd 1.3 % v/v content of DMSO for compound 1 and 2,respectively).
Ta ble 4r eports only the absorption data recorded at the time zero. Similar to other our complexes, [14, 49] contrary to DMSO medium, some decreases of the band intensities were quickly observed for both complexes upon dissolution in saline, reachingasteady condition after three hours. Overall, the maximum positiono ft he bands is essentially unchanged over time. This points out that the goldc enter keeps the + 3 oxidation state thanks to the stabilizing effects played by the chelating dithiocarbamato ligand. [50] The drop in spectral intensity can be ascribed to the progressive hydrolysis of gold(III)-bromide (compound 1)a nd gold(III)-chloride (compound 2) bonds, leadingt ot he water-soluble aquo complexes and, ultimately,t ot he precipitation of the hydroxo derivatives (verified by elemental and far FT-IR analyses). In addition, compound 1 undergoes more rapid hydrolysis compared to the complex 2 with an absorbance decrease overo ne hour of about1 1% and 1%,r espectively, ( Figure 3 ). This behavior highlights ah igher intrinsic reactivity of the bromide derivative with respect to the chloride one under physiological-like conditions. In fact, bromide ranks lower than chloride within the experimental spectrochemical series of ligands, [51] thus pointingout agreater capacityf or the latter to cause d-orbital splitting. The larger the crystal field stabilization energy,t he strongert he metalligand bond, in agreement with our previouslyd escribed FT-IR data on the AuÀXbond strength.
Biological assays
Compounds 1and 2i nduce dose-dependent tumor cell death Treatmentw ith both compounds 1 and 2 resulted in ar apid (three-hour) dose-dependent decrease of cell viability in the following human cancer cell lines:t he highly aggressive SAOS2o steosarcoma cells, the HeLa cervical adenocarcinomac ells, the HCT116 colorectal carcinomac ells, and the mouse embryonic fibroblasts, obtained from mice where the bona fide tumor suppressor gene NF1 was genetically ablated (MEF-NF1 À/À )( Ta ble 5).
Our dataa lso show that compound 1 is the most promising anticancer molecule, as it induced am arkedlyh igher cytotoxicity than compound 2 in all tested cell types (Figure 4, a-d) , suggesting that the presence of bromides instead of chlorides in the gold coordination sphere profoundly affects the biological efficacy of the potential drug. Cisplatin was tested as arefer- ence compound under the same experimental conditions recording no significant cytotoxicity after three hours of treatment.
Compound 1increases intracellularreactive oxygen species (ROS) and sensitizest he permeabilitytransition pore (PTP) to opening
In the light of the antiproliferation screening, we then conducted the subsequent biological studies on the more active compound 1.
Recently,w eh ave shown [52] that the gold(III)-dithiocarbamato complex AuL12 causes ar ise of mitochondrial superoxide levels that kills tumor cellsb yi nducing ROS-dependent opening of the PTP.T he PTPi salarge channel located in the inner mitochondrial membrane, whose opening causes mitochondrial depolarization and swelling, leading to rupture of the outer mitochondrial membrane, releaseo fC a 2 + and of pro-apoptotic proteins,a nd then cell death. [53, 54] Therefore, we evaluated whether the cytotoxicity elicited by compound 1 is mediated by as imilar oxidative stress,whichwould prompt cell death by selectively triggering PTP opening in neoplastic cells. We performed these experiments on MEF-NF1 À/À ,o btainedf rom knockout mice for the onco-suppressor gene NF1.S uch ag ene encodes neurofibromin( Nf1), which negatively regulates Ras, [55] am aster protooncogenew hose hyperactivation is the most common oncogenic event, which prompts cell proliferation, apoptosis resistance, andm etabolic rearrangements. [56] In addition to Ras hyperactivation, the ablation of the NF1 gene also resultsint he genetic disease neurofibromatosis, characterized by the occurrence of diverset umor types. [57] Based on these considerations, MEF-NF1 À/À cells constitute ag ood model to check the antiblastic activity of our compounds.
The gold(III) compound 1 induced ar ise in ROS levels (Figure 5a) . Kinetic experiments showed that the ROS increase was extremelyr apid, reaching am aximum after 60 minutes (Figure 5a) . To ascertain whether compound 1 is capable of eliciting PTP opening, we performed aC a 2 + retention capacity (CRC) analysis, which evaluates PTP modulation in as emiquantitative wayt hrough the assessment of the amount of Ca 2 + taken up by mitochondriab efore pore opening. [58] As shown in Figure 5b ,c ompound 1 triggered ad ose-dependent CRC decrease on isolated liver mitochondria, which constitutes the standard model when setting CRC experiments, because hepatocytes are endowed with ah igh number of mitochondria. Inhibition of Ca 2 + releasef rom mitochondria by ac ontrol treatment of cyclosporine A( CSA), aw ell-known PTPi nhibitor,c onfirmed that CRC experiments werea ssessing PTP modulation, and that the observed calcium release is due to PTP opening. These data suggest that compound 1 seems to promote cell death by inducingP TP opening, so we also carriedo ut CRC experiments on the MEF-NF1
À/À cells. [58] We found that at hreehour treatment with the gold(III) complex 1 caused ad ose-dependentC RC shortening, that is PTP opening, on this cellular model as well (Figure5c). Furthermore, we performed parallel experiments in the presence of the ROS-scavenging compound Trolox, finding no changes in the effect of compound 1 on PTP opening. These experiments suggest that the cell death commitment induced by compound 1 is not only associated with its verified ability to induce ROS, but it is likely due to other ROS-independent pathways, that ultimately lead to PTP opening.
Conclusions
In the last four decades, the unquestionable therapeutic success of the anticancer drug cisplatin has prompted the design, www.chemistryopen.org synthesis, and biological development of several metal-based potentialc hemotherapeutics. On the whole, our gold(III) complexes of the type [AuX 2 (dtc)] (X = Cl, Br;d tc = variousd ithiocarbamates) stand out among others for their capability to strongly inhibit tumor growth both in vitro and in vivo by mechanisms of action differing from those recognized for the clinically-establishedp latinum drugs. [59] In this work, our novel compounds 1 and 2 showed am arked cytotoxicity towards different tumor cell types in as hort treatment time (Table 5) .
In order to exploit the chemotherapeutic potential of this class of gold(III) derivatives, it is mandatory to dissect their mode of action on target cells. One possibility is that tumor cell death is caused by oxidative stress.I tm ust be underlined that malignant cells are extremelys ensitive to oxidative stress as they are characterizedb yc omplex metabolic rearrangements,w ith an enhancement of glucose utilization andaconcomitantd ecrease of mitochondrial respiration (the Warburg effect [60] [61] [62] ). As respiratory chain complexes are the major producers of ROS inside cells, [63] downmodulation of their activity enhances ROS generation, forcingc ancerc ells to set an ovel homeostatic redox equilibrium by simultaneously inducing antioxidantd efenses. [64] Thus, neoplasms might be sensitized to oxidative stress with respect to nontransformed tissues,a sa ny increasei nR OS levels could unbalance their redox equilibrium by overpoweringt heir residual anti-oxidant capabilities.
In this research, we observed that the great activity of compound 1 on NF1 À/À MEFs is paralleled by an increase in ROS levels. This oxidative assault is able to induce the PTP,amitochondrial channel whose opening commits cells to death. [54] However,t he presence of the scavenger Trolox does not affect the ability of compound 1 to trigger the pore transition in MEF-NF1 À/À cells, thus suggesting the oxidative stress can only partially account for the efficacy of our potential drug. The chemicalb ehavior of both complexes was also studied under physiological-like conditions by UV/Vis spectrophotometry in www.chemistryopen.org order to gain insights into the stabilityofthe gold(III) coordination sphere and to connect it with the degree of cytotoxicity of the compounds.I nt his regard, the organic/inorganic nature of the ligands can playamajor role in modulating anticancer properties of the metal ion. On the whole, the analysis of the collected chemical data and their comparison with the biological results brings out as tructure-activity relationship. In particular,w ef ound that lability of the halogen-gold bond perfectly matches the biological effects of the complexes. In fact, it turned out that the faster the hydrolysis process of the AuÀBr/ Cl bond, the greater the chemotherapeutic effect observed, thus accounting for the stronger cytotoxicity of complex 1 in comparison with complex 2.S uch ap henomenon is in agreement with the findings reported by Casini et al. for other gold(III) anticancer agents. [5] In other words, our compounds undergo an "activation" process (i.e.r elease of one or both halide ligandsf rom the tetracoordinated gold(III) center), required to react with the possible cellular targets and, hence, to trigger the antitumor effects. On the other hand, based on the redox properties (oxidizing) of the metal ion, ar eductive step for the Au III center cannotb er uled out ap riori when studying the mechanism of action of this class of potentialpharmaceuticals. 
Experimental Section Chemicals
Instrumentation and general procedures
Elemental analysis was performed using aC arlo Erba 1108 CHNS-O microanalyser (CE Instruments Ltd.,W igan, UK). )a taheating rate of 5 8Cm in À1 , using alumina as reference.
Electronic spectra were acquired at 37 8Ci nt he range 250-500 nm using aC ary 100 UV/Vis double beam spectrophotometer (Agilent, Santa Clara, USA) (1 cm optical path, quartz cuvettes), using fresh solutions of the samples in DMSO. With respect to the studies in 0.9 %( w / v )N aCl solution, compounds 1 and 2 were dissolved in DMSO beforehand and subsequently diluted with saline solution (~1% v/v DMSO) to yield af inal concentration of 100 mm.F or the kinetic studies, the initial time (time zero) was set upon the complete dissolution of the complex.
Synthesis of the gold(III) complexes
To an aqueous solution of KAuX 4 ·2H 2 O( X = Br,C l; 0.6 mmol), the ligand NH 4 (PDT) (0.6 mmol) was added dropwise while stirring at rt, giving rise to the immediate precipitation of as olid. After 10 min, the crude product was isolated by centrifugation (5,000 rpm, 15 min)and washed with H 2 Oa nd diethyl ether.B oth complexes were then dried in vacuo in the presence of P 4 4 ,a nd diethyl ether;F T-IR (KBr): ṽ max = 2980-2866 (n,C H 2 ), 1586 (n,N À CSS), 1439 (n,C H 2 ), 942 cm À1 (n a ,S À C À S);F T-IR (Nujol): ṽ max = 538 (n s ,S À C À S), 413 (n a , SÀAuÀS), 375 (n s ,S À AuÀS), 362 (n a ,C l À AuÀCl), 315 cm À1 (n s ,C l À AuÀCl); 
Cell viability assay
Cell viability was measured using the Resazurin-based In Vitro To xicology Assay Kit (Sigma-Aldrich, St. Louis, USA). Cells (40,000/well) were plated into 96-well microplates the day before the experiment. After the 3h treatments with compounds 1 or 2,t he Resazurin-based reagent was added. Then, cells were maintained at 37 8Cf or an additional 2h,a nd the absorbance at 595 nm was detected using the iMark microplate reader (BioRad, Hercules, USA). All treatments were carried out in DMEM supplemented with l-Glutamine (Euroclone), penicillin (100 UmL À1 ,E uroclone), and streptomycin (100 mgmL À1 ,E uroclone) distributed into each well (200 mL) of a9 6-well cell culture plate. Stock solutions of all complexes were made in DMSO and then diluted with complete medium in such aw ay that the final amount of solvent in each well did not exceed 0.4 %( v / v ). Cytotoxicity data were expressed as IC 50 values (Table 5) , that is the concentration of the complex inducing a5 0% decrease in cell number compared with control cultures.
ROS measurements
ROS measurements were performed using the probe 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H 2 DCFDA, 1 mm,M olecular Probes, Carlsbad, USA). Cells (10,000/well) were plated the day before the experiment, and CM-H 2 DCFDA was added with treatments in DMEM supplemented with 0.5 %f etal bovine serum (FBS) without bicarbonate. Cells were maintained at 37 8Cw ithout CO 2 during the experiment, and the fluorescence (l ex = 485 nm, l em = 538 nm) was recorded using aF luoroskan Ascent FL plate reader (Thermo Fisher Scientific, Waltham, USA) at different time points.
Measurement of mitochondrial Ca 2 + + retention capacity
The CRC assay was used to assess PTP opening by following trains of Ca 2 + pulses which were measured fluorimetrically at 25 8Ci nt he presence of the Ca 2 + indicator Calcium Green-5N (1 mm, l ex = 505 nm, l em = 535 nm, Molecular Probes). We performed CRC experiments either on isolated mitochondria or on whole cells placed in an isotonic buffer (130 mm KCl, 1 mm Pi-Tris (Pi:i norganic phosphate), 10 mm Tris/3-(N-morpholino)propansulfonic acid (MOPS), 10 mm Tris/ethylene glycol tetraacetic acid (EGTA), 5mm glutamate/2.5 mm malate, pH 7.4). Whole-cell CRC was carried out after 3h treatment with compound 1,f ollowed by the plasma membrane permeabilization with the nonionic detergent digitonin, which is highly selective for cholesterol-enriched membranes and does not damage the mitochondrial membranes. Cells were washed with phosphate-buffered saline (PBS, pH 7.4) and then permeabilized with 150 mm digitonin (15 min, 4 8C) in ab uffer composed of 130 mm KCl, 1 mm Pi-Tris, 10 mm Tris/MOPS, and 1mm Tris/EGTA( pH 7.4). Digitonin was then washed away by spinning cells in the same buffer (15,000 rpm, 30 min) and changing the EGTA/Tris concentration to 0.1 mm,a nd the number of cells was carefully assessed before starting each experiment. Mitochondria (0.5 mg mL
À1
)o rp ermeabilized cells (7 10 6 cells per experiment) were then placed in the presence of the Ca 2 + indicator CalciumGreen-5N, which does not permeate mitochondria, and were exposed to Ca 2 + spikes (10 mm and 5 mm,r espectively). Drops in fluorescence were used to assess mitochondrial Ca 2 + uptake. PTP opening was detected as an increase in fluorescence. Pore inhibitors, such as cyclosporine A, are expected to enhance the threshold of Ca 2 + concentration required to trigger the permeability transition, that is, the number of spikes before as udden and marked fluorescence increase occurs.
